E

Eone Diagnomics Genome Center Co Ltd
KOSDAQ:245620

Watchlist Manager
Eone Diagnomics Genome Center Co Ltd
KOSDAQ:245620
Watchlist
Price: 415 KRW -5.25% Market Closed
Market Cap: 57.5B KRW

Gross Margin
Eone Diagnomics Genome Center Co Ltd

21.5%
Current
14%
Average
44.2%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
21.5%
=
Gross Profit
4.4B
/
Revenue
20.3B

Gross Margin Across Competitors

No Stocks Found

Eone Diagnomics Genome Center Co Ltd
Glance View

EONE DIAGNOMICS GENOME CENTER Co., Ltd. engages in the operation as a genomics company providing a range of clinical and consumer genetic services. The company is headquartered in Incheon, Incheon. The company went IPO on 2018-06-26. The firm is engaged in non-invasive prenatal tests (NIPT), newborn screening tests, ophthalmologist specialist genome analysis tests, customized disease prediction tests, and direct to consumer (DTC) genetic tests, among others. In addition, the Company is developing genome-related software.

Intrinsic Value
190.48 KRW
Overvaluation 54%
Intrinsic Value
Price
E
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
21.5%
=
Gross Profit
4.4B
/
Revenue
20.3B
What is the Gross Margin of Eone Diagnomics Genome Center Co Ltd?

Based on Eone Diagnomics Genome Center Co Ltd's most recent financial statements, the company has Gross Margin of 21.5%.

Back to Top